Is there a Single “Best” Platform or will it be “Fit to Purpose”?
Time: 10:00 am
day: Day Two
- Analysing the advantages, disadvantages and comparisons of the DNA, Peptide, RNA, and Virus-based and other novel vaccine platforms
- Harmonisation of clinical outcomes and immune correlates
- Considering if we can we get better at predictive animal models?
- Questioning what other signals we need to provide to the immune system, either built into the vaccine or given concomitantly (checkpoints, costims, cytokines, innate immunity boosters, etc.